People · Operator
Named in public records as an officer, director or promoter · active 2018–2021 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| LikeMinds, Inc./DE | — | Biotechnology | Series A | $6.4M | $26.7M | 2018 |
Robert G. Langer at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Robert G. Langer on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Paul G. Sekhri | 1 | 2 |
| Peter G. Savas | 1 | 2 |
| Robert G. Van Nostrand | 1 | 1 |
| Kenneth G. Rice | 1 | 1 |
| Gary G. Frashier | 1 | 1 |
| Vicki G. Zikopoulou | 1 | 1 |
| Henry G. Brem | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.